Pal, S. K., He, M., Chen, L., Yang, L., Pillai, R., Twardowski, P., . . . Jones, J. O. (2017). Synaptophysin expression on circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide. Urol Oncol.
Citação norma ChicagoPal, Sumanta Kumar, Miaoling He, Lin Chen, Lixin Yang, Raju Pillai, Przemyslaw Twardowski, JoAnn Hsu, Marcin Kortylewski, and Jeremy O. Jones. "Synaptophysin Expression On Circulating Tumor Cells (CTCs) in Patients With Castration Resistant Prostate Cancer (CRPC) Undergoing Treatment With Abiraterone Acetate or Enzalutamide." Urol Oncol 2017.
MLA CitationPal, Sumanta Kumar, et al. "Synaptophysin Expression On Circulating Tumor Cells (CTCs) in Patients With Castration Resistant Prostate Cancer (CRPC) Undergoing Treatment With Abiraterone Acetate or Enzalutamide." Urol Oncol 2017.